ZIM
JAZZ icon

Zacks Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Zacks Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,331
Closed -$1.84M – 554
2019
Q4 		$1.84M Buy
12,331
+226
+2% +$30.8K 0.03% 286
2019
Q3 		$1.55M Buy
12,105
+699
+6% +$93.7K 0.03% 312
2019
Q2 		$1.63M Buy
+11,406
New +$1.53M 0.03% 310
2014
Q1 		– Sell
-3,288
Closed -$416K – 719
2013
Q4 		$416K Sell
3,288
-5,758
-64% -$596K 0.02% 467
2013
Q3 		$832K Buy
9,046
+2,860
+46% +$231K 0.04% 247
2013
Q2 		$425K Buy
+6,186
New +$378K 0.02% 363

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Zacks Investment Management's JAZZ Position: Q1 2020 in Review

Zacks Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2020, closing a stake of 12,331 shares — an estimated $1.84M sold.

Zacks Investment Management first reported a position in JAZZ in Q2 2013 and held it in 6 quarters. The position peaked at $1.84M in Q4 2019. 407 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

  • Zacks Investment Management reported no remaining Jazz Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Zacks Investment Management sold 12,331 Jazz Pharmaceuticals shares in Q1 2020, an estimated $1.84M.
  • Zacks Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Zacks Investment Management's Jazz Pharmaceuticals position peaked at $1.84M in Q4 2019.
  • 407 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on Zacks Investment Management's 13F filing for Q1 2020, filed 15 May 2020.